Research Theme
Tissue Specific Carcinogenesis (TSC) focuses on unraveling molecular mechanisms of tissue specific carcinogenesis driving therapy resistance in cancer. The ultimate goal of this Theme is to build an infrastructure and research network that improves how cancer patients are diagnosed, treated and understanding the mechanisms behind therapy resistance in cancer, to identify potential biomarkers of drug resistance/ sensitivity and to identify new targets and treatment modalities to overcome therapy resistance.
Theme Leads
Prof Shazib PERVAIZ
A/Prof TAN Shao Peng, David
Research is focused on the development of biomarkers and novel therapeutic agents in gynaecological cancers; in understanding the mechanisms of treatment response and resistance in these cancers, with the aim of developing biomarkers to help stratify patients into optimal treatment strategies.
Theme Members - Secondary
Prof Reshma TANEJA
Research focus is on cellular differentiation mechanisms in normal cells and in cancer. Interest are in cancer, epigenetics and gene regulation.
Prof Herbert SCHWARZ
Research focus is on studying the role of the CD137 receptor / ligand system in the regulation of immune responses and aim to translate our findings to novel therapies.
Prof Herbert SCHWARZ
Research focus is on studying the role of the CD137 receptor / ligand system in the regulation of immune responses and aim to translate our findings to novel therapies.